# Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

> **NCT00816335** · EARLY_PHASE1 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 65 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** PET/CT scan
- **DRUG:** 18F-FDG Injection
- **PROCEDURE:** Preoperative 18F-FDG PET/CT Scan
- **DRUG:** 18F-FDG for patients with Bladder Cancer
- **PROCEDURE:** Surgical Procedure
- **PROCEDURE:** Specimen PET/CT Scan

## Key facts

- **NCT ID:** NCT00816335
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2016-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816335, "Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00816335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*